Treatment of gastroparesis with botulinum toxin in patient after allogenic bone marrow transplantation

Treatment of gastroparesis with botulinum toxin in patient after allogenic bone marrow transplantation

Show other versions (1)

The case report of botulinum toxin treatment of gastroparesis in a patient following allogenic bone marrow transplantation is described. The causes of gastroparesis and methods of prevention and treatment are discussed. It was noted that pyloric injection of botulinum toxin can improve symptoms and...

Full description

Bibliographic Details
Main Authors:	G M Galstyan, M V Pashkova, O Y Popova, P M Makarova, D S Dubnyak, L A Kuzmina, E N Parovichnikova
Format:	Article
Language:	Russian
Published:	"Consilium Medicum" Publishing house 2018-01-01
Series:	Терапевтический архив
Subjects:	gastroparesis bone marrow transplantation botulinum toxin pyloric injection immunosuppressive therapy cyclosporine a tacrolimus ganciclovir foscarnet cytomegalovirus infection «graft-versus-host disease»
Online Access:	https://ter-arkhiv.ru/0040-3660/article/viewFile/32702/pdf

Similar Items

Treatment of gastroparesis with botulinum toxin in patient after allogenic bone marrow transplantation
by: G.M. GALSTYAN, et al.
Published: (2018-01-01)

Comparison of intravitreal ganciclovir monotherapy and combination with foscarnet as initial therapy for cytomegalovirus retinitis
by: Jing-Jing Fan, et al.
Published: (2018-10-01)

CMV and HSV-2 myeloradiculitis in an HIV infected patient
by: Adriana Pinto, et al.
Published: (2011-06-01)

Current Drugs to Treat Infections with Herpes Simplex Viruses-1 and -2
by: Lauren A. Sadowski, et al.
Published: (2021-06-01)

Clinical laboratory aspects of one-component immunosuppression during liver transplantation
by: M. Sh. Khubutia, et al.
Published: (2018-08-01)

Evaluation of cytomegalovirus treatment in transplant patients before and during the foscarnet nationwide shortage
by: Doehnert, Deborah, et al.
Published: (2012)

Evaluation of Cytomegalovirus Treatment in Transplant Patients Before and During the Foscarnet Nationwide Shortage
by: Doehnert, Deborah, et al.
Published: (2012)

In vitro activity of six antiviral drugs against equid alphaherpesvirus type 1 indicates ganciclovir as promising drug for in vivo studies
by: Amanda Lovato de Oliveira, et al.
Published: (2018-12-01)

Foscarnet-Resistant Cytomegalovirus Esophagitis with Stricturing
by: Vinaya Gaduputi, et al.
Published: (2013-01-01)

Sirolimus and tacrolimus rather than cyclosporine A cause bone loss in healthy adult male rats
by: Mercedes Rubert, et al.
Published: (2015-06-01)

A possible coincidence of cytomegalovirus retinitis and intraocular lymphoma in a patient with systemic non-Hodgkin’s lymphoma
by: Svozílková Petra, et al.
Published: (2013-01-01)

Relations exposition-effets et pharmacogénétique du ganciclovir chez le patient transplanté
by: Billat, Pierre-André
Published: (2015)

Mirtazapine for symptom control in refractory gastroparesis
by: Malamood M, et al.
Published: (2017-03-01)

Current perspectives on the management of gastroparesis
by: Rattansingh A, et al.
Published: (2005-01-01)

Lack of resistance-associated mutations in UL54 and UL97 genes of circulating Cytomegalovirus strains isolated in a medical center in Taiwan
by: Pei-Lan Shao, et al.
Published: (2012-08-01)

Bilateral cytomegalovirus retinitis in a healthy infant
by: Seyedeh Maryam Hosseini, et al.
Published: (2017-03-01)

Diabetic gastroparesis: current challenges and future prospects
by: Avalos DJ, et al.
Published: (2018-09-01)

KSHV Targeted Therapy: An Update on Inhibitors of Viral Lytic Replication
by: Natacha Coen, et al.
Published: (2014-11-01)

Reprogramming of gastric motility with "pulse therapy" (metoclopramide and erythromycin) in severe gastroparesis
by: Shamik Shah, et al.
Published: (2013-01-01)

Analyses of AUC<sub>(0–12)</sub> and C<sub>0</sub> Compliances within Therapeutic Ranges in Kidney Recipients Receiving Cyclosporine or Tacrolimus
by: Aurelija Radzevičienė, et al.
Published: (2020-12-01)

Clinical experience of conversion from cyclosporine to tacrolimus prolonged-release in stabilized kidney transplant patients
by: Karel Krejci, et al.
Published: (2016-09-01)

The effects of immunosuppressive agents on inflammatory response in septic rats
by: Filiz Ali, et al.
Published: (2010-12-01)

Management of diabetic gastroparesis
by: Badr M Aljarallah
Published: (2011-01-01)

Suffering in Silence: Is Gastroparesis Underdiagnosed?
by: Dennis J. Baumgardner
Published: (2019-04-01)

The Natural Flavonoid Compound Deguelin Inhibits HCMV Lytic Replication within Fibroblasts
by: Masatoshi Nukui, et al.
Published: (2018-11-01)

La caractérisation des mutations dans le gène UL97 du cytomégalovirus conférant la résistance au ganciclovir
by: Martin, Mélanie
Published: (2006)

Presumed neonatal cytomegalovirus retinitis treated with intravenous ganciclovir
by: A Suganya, et al.
Published: (2020-01-01)

Cytomegalovirus-associated esophageal ulcer in an immunocompetent infant: When should ganciclovir be administered?
by: Hyo-Jeong Jang, et al.
Published: (2012-12-01)

Cytomegalovirus retinitis in Cape Town, South Africa: Clinical management and outcomes
by: Steven R J Lapere, et al.
Published: (2017-06-01)

Cytomegalovirus Retinitis in an Immunocompromised Infant:A Case Report and Review of the Literature
by: A. Mota, et al.
Published: (2011-08-01)

Use of tacrolimus to prevent acute kidney graft rejection in sensitized patients
by: O. N. Rzhevskaya, et al.
Published: (2018-08-01)

Function of external respiration in patients after kidney transplantation under conditions of immunosuppressive therapy.
by: O. V. Kuryata, et al.
Published: (2018-04-01)

Correlation between symptoms of diabetic gastroparesis and results of gastric scintigraphy
by: Grad Simona, et al.
Published: (2012-02-01)

Treatment of Diabetic Gastroparesis by Complementary and Alternative Medicines
by: Hao Liu, et al.
Published: (2015-08-01)

Gastroparesis in a Patient with Gastric AL Amyloidosis
by: Matthew Hoscheit, et al.
Published: (2018-06-01)

Management of Dyspepsia and Gastroparesis in Patients with Diabetes. A Clinical Point of View in the Year 2021
by: Silvia Bonetto, et al.
Published: (2021-03-01)

In‐hospital mortality in gastroparesis population and its predictors: A United States‐based population study
by: Saad Saleem, et al.
Published: (2021-03-01)

Cytomegalovirus management after allogeneic hematopoietic stem cell transplantation: A mini-review
by: Chieh-Lin Jerry Teng, et al.
Published: (2021-06-01)

Development of a Motility Frailty Index in Patients with Gastroparesis
by: Jared Winston, et al.
Published: (2021-04-01)

Experience of Using the Antiviral Therapy of Generalized Congenital Cytomegalovirus Infection
by: G. V. Petrova, et al.
Published: (2016-06-01)

Cannot write session to /tmp/vufind_sessions/sess_3esd4li6c78lhhsfsmtm7ng1s7